AbbVie Inc. Logo

AbbVie Inc.

A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.

ABBV | US

Overview

Corporate Details

ISIN(s):
US00287Y1091
LEI:
Country:
United States of America
Address:
1 NORTH WAUKEGAN ROAD, 60064 NORTH CHICAGO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

AbbVie Inc. is a global, research-based biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of innovative medicines and therapeutic solutions. The company focuses on addressing complex and serious health issues across key therapeutic areas, including immunology, oncology, neuroscience, and virology. AbbVie's strategy emphasizes deep scientific expertise and a patient-centric approach to solve significant health challenges. Established in 2013 as a spin-off from Abbott Laboratories, the company collaborates extensively with external partners to advance groundbreaking science and deliver a lasting impact on people's lives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbbVie Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbbVie Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AbbVie Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Repare Therapeutics Inc. Logo
Develops precision oncology drugs using a CRISPR platform for cancers with genomic instabilities.
United States of America RPTX
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia REPL
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden RESP
REVELATION BIOSCIENCES, INC. Logo
Develops therapies that reprogram the innate immune system to reduce inflammation-related damage.
United States of America REVB
REVIVA PHARMACEUTICALS HOLDINGS, INC. Logo
Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.
United States of America RVPH
Revolution Medicines, Inc. Logo
A clinical-stage oncology company developing targeted therapies for RAS-addicted cancers.
United States of America RVMD
REVVITY, INC. Logo
Provides life sciences & diagnostics technologies to support workflows from discovery to cure.
United States of America RVTY
REYON PHARMACEUTICAL CO., LTD Logo
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
South Korea 102460
Rezolute, Inc. Logo
Developing therapies for rare metabolic diseases, focusing on hyperinsulinism-caused hypoglycemia.
United States of America RZLT
RHYTHM PHARMACEUTICALS, INC. Logo
Develops precision medicines for rare genetic diseases causing severe obesity and hyperphagia.
United States of America RYTM

Talk to a Data Expert

Have a question? We'll get back to you promptly.